Home > Insider Trading > Filing (0001209191-20-041549)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
879169	Incyte Corp	INCY	Services-Commercial Physical & Biological Research (8731)	943136539

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1760682	Dashyant Dhanak	1801 Augustine Cut-Off Wilmington DE 19803	Evp & Chief Scientific Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2020-07-02	6,661	$0.00	26,648	No	4	A	Direct
Common Stock	Disposition	2020-07-02	1,057	$106.47	25,591	No	4	F	Direct
Common Stock	Acquisiton	2020-07-06	961	$65.42	26,552	No	4	M	Direct
Common Stock	Disposition	2020-07-06	961	$106.58	25,591	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	A	Direct
No	4	F	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Employee Stock Option (right to buy)	Acquisiton	2020-07-02	12,743	$0.00	12,743	$106.47
Common Stock	Non-Qualified Stock Option (right to buy)	Disposition	2020-07-06	961	$0.00	961	$65.42

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
12,743		2030-07-01	No	4	A	Direct
35,564		2028-12-10	No	4	M	Direct

Footnotes

Represents award of restricted stock units ("RSUs") that will vest 25% annually over four years, subject to Dashyant Dhanak's continued service with the issuer through the applicable vesting dates. The RSUs may be settled only for shares of common stock on a one-for-one basis.
Represents shares withheld automatically by the Issuer to satisfy tax withholding obligations due at settlement of restricted stock units or earned performance shares previously reported in Table I as common stock.
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person.
Including the July 2, 2020 Restricted Stock Unit Grant, this includes an aggregate of 22,052 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance shares that have not vested.
Beginning July 2, 2020, options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years.
Beginning December 10, 2018, options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years.